The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus

Retrovirology

Volumn 9, Issue , 2012, Pages

  van der Kuyl, Antoinette C ^a   Berkhout, Ben ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; DOUBLE STRANDED DNA; GENOMIC DNA; GENOMIC RNA; MESSENGER RNA; NUCLEOTIDE; RNA DIRECTED DNA POLYMERASE; VIRUS DNA; VIRUS RNA;

ANTIVIRAL RESISTANCE; BIOCHEMICAL COMPOSITION; CODON; DRUG EFFECT; GENE EXPRESSION REGULATION; GENOME ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INNATE IMMUNITY; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN ANALYSIS; REGULATORY SEQUENCE; REVERSE TRANSCRIPTION; REVIEW; RNA STRUCTURE; STRUCTURAL GENE; TRANSLATION REGULATION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS GENOME; VIRUS IMMUNITY; VIRUS INACTIVATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; BASE COMPOSITION; CODON; GENES, VIRAL; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; NUCLEIC ACID CONFORMATION; RNA, VIRAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS;

EID: 84868267075     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-9-92     Document Type: Review

References (124)

1. Kypr J, Mrazek J. Unusual codon usage of HIV. Nature 1987, 327:20.
2. Kypr J, Mrazek J, Reich J. Nucleotide composition bias and CpG dinucleotide content in the genomes of HIV and HTLV 1/2. Biochim Biophys Acta 1989, 1009:280-282. 10.1016/0167-4781(89)90114-0, 2597678.
3. Bronson EC, Anderson JN. Nucleotide composition as a driving force in the evolution of retroviruses. J Mol Evol 1994, 38:506-532. 10.1007/BF00178851, 8028030.
4. Berkhout B, van Hemert FJ. The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins. Nucleic Acids Res 1994, 22:1705-1711. 10.1093/nar/22.9.1705, 308053, 8202375.
5. van Hemert FJ, Berkhout B. The tendency of lentiviral open reading frames to become A-rich: constraints imposed by viral genome organization and cellular tRNA availability. J Mol Evol 1995, 41:132-140.
6. Berkhout B, Grigoriev A, Bakker M, Lukashov VV. Codon and amino acid usage in retroviral genomes is consistent with virus-specific nucleotide pressure. AIDS Res Hum Retroviruses 2002, 18:133-141. 10.1089/08892220252779674, 11839146.
7. Snoeck J, Fellay J, Bartha I, Douek DC, Telenti A. Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints. Retrovirology 2011, 8:87. 10.1186/1742-4690-8-87, 3229471, 22044801.
8. Sharp PM, Hahn BH. The evolution of HIV-1 and the origin of AIDS. Philos Trans R Soc Lond B Biol Sci 2010, 365:2487-2494. 10.1098/rstb.2010.0031, 2935100, 20643738.
9. Plantier JC, Leoz M, Dickerson JE, De OF, Cordonnier F, Lemee V, et al. A new human immunodeficiency virus derived from gorillas. Nat Med 2009, 15:871-872. 10.1038/nm.2016, 19648927.
10. Gifford RJ, Katzourakis A, Tristem M, Pybus OG, Winters M, Shafer RW. A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution. Proc Natl Acad Sci U S A 2008, 105:20362-20367. 10.1073/pnas.0807873105, 2603253, 19075221.
11. Gilbert C, Maxfield DG, Goodman SM, Feschotte C. Parallel germline infiltration of a lentivirus in two Malagasy lemurs. PLoS Genet 2009, 5:e1000425. 10.1371/journal.pgen.1000425, 2651035, 19300488.
12. Katzourakis A, Tristem M, Pybus OG, Gifford RJ. Discovery and analysis of the first endogenous lentivirus. Proc Natl Acad Sci U S A 2007, 104:6261-6265. 10.1073/pnas.0700471104, 1851024, 17384150.
13. van der Loo W, Abrantes J, Esteves PJ. Sharing of endogenous lentiviral gene fragments among leporid lineages separated for more than 12 million years. J Virol 2009, 83:2386-2388. 10.1128/JVI.01116-08, 2643718, 19109386.
14. Keckesova Z, Ylinen LM, Towers GJ, Gifford RJ, Katzourakis A. Identification of a RELIK orthologue in the European hare (Lepus europaeus) reveals a minimum age of 12 million years for the lagomorph lentiviruses. Virology 2009, 384:7-11. 10.1016/j.virol.2008.10.045, 19070882.
15. Cui J, Holmes EC. Endogenous lentiviruses in the ferret genome. J Virol 2012, 86:3383-3385. 10.1128/JVI.06652-11, 3302300, 22238305.
16. Damond F, Worobey M, Campa P, Farfara I, Colin G, Matheron S, et al. Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification. AIDS Res Hum Retroviruses 2004, 20:666-672. 10.1089/0889222041217392, 15242544.
17. Zhu T, Korber BT, Nahmias AJ, Hooper E, Sharp PM, Ho DD. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 1998, 391:594-597. 10.1038/35400, 9468138.
18. Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, Bunce M, et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008, 455:661-664. 10.1038/nature07390, 18833279.
19. Jonassen TO, Stene-Johansen K, Berg ES, Hungnes O, Lindboe CF, Froland SS, et al. Sequence analysis of HIV-1 group O from Norwegian patients infected in the 1960s. Virology 1997, 231:43-47. 10.1006/viro.1997.8510, 9143301.
20. Berkhout B, de Ronde A. APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations. AIDS 2004, 18:1861-1863. 10.1097/00002030-200409030-00022, 15316354.
21. Houzet L, Paillart JC, Smagulova F, Maurel S, Morichaud Z, Marquet R, et al. HIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms. Nucleic Acids Res 2007, 35:2695-2704. 10.1093/nar/gkm153, 1885669, 17426127.
22. Rulli SJ, Hibbert CS, Mirro J, Pederson T, Biswal S, Rein A. Selective and nonselective packaging of cellular RNAs in retrovirus particles. J Virol 2007, 81:6623-6631. 10.1128/JVI.02833-06, 1900105, 17392359.
23. Lever A, Gottlinger H, Haseltine W, Sodroski J. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J Virol 1989, 63:4085-4087. 251012, 2760989.
24. Heng X, Kharytonchyk S, Garcia EL, Lu K, Divakaruni SS, LaCotti C, et al. Identification of a minimal region of the HIV-1 5'-leader required for RNA dimerization, NC binding, and packaging. J Mol Biol 2012, 417:224-239. 10.1016/j.jmb.2012.01.033, 3296369, 22306406.
25. Darlix JL, Godet J, Ivanyi-Nagy R, Fosse P, Mauffret O, Mely Y. Flexible nature and specific functions of the HIV-1 nucleocapsid protein. J Mol Biol 2011, 410:565-581. 10.1016/j.jmb.2011.03.037, 21762801.
26. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW, Swanstrom R, et al. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 2009, 460:711-716. 10.1038/nature08237, 2724670, 19661910.
27. Kumar M, Keller B, Makalou N, Sutton RE. Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther 2001, 12:1893-1905. 10.1089/104303401753153947, 11589831.
28. Lang DM. Circuit assemblages derived from net dinucleotide values provide a succinct identity for the HIV-1 genome and each of its genes. Virus Genes 2008, 36:11-26. 10.1007/s11262-007-0128-6, 17987374.
29. Rima BK, McFerran NV. Dinucleotide and stop codon frequencies in single-stranded RNA viruses. J Gen Virol 1997, 78(Pt 11):2859-2870.
30. Pedersen AK, Wiuf C, Christiansen FB. A codon-based model designed to describe lentiviral evolution. Mol Biol Evol 1998, 15:1069-1081. 10.1093/oxfordjournals.molbev.a026006, 9718734.
31. Shpaer EG, Mullins JI. Selection against CpG dinucleotides in lentiviral genes: a possible role of methylation in regulation of viral expression. Nucleic Acids Res 1990, 18:5793-5797. 10.1093/nar/18.19.5793, 332316, 2170945.
32. Hodgkinson A, Eyre-Walker A. Variation in the mutation rate across mammalian genomes. Nat Rev Genet 2011, 12:756-766. 10.1038/nrg3098, 21969038.
33. Adhya D, Basu A. Epigenetic modulation of host: new insights into immune evasion by viruses. J Biosci 2010, 35:647-663. 10.1007/s12038-010-0072-9, 21289446.
34. Karlin S, Doerfler W, Cardon LR. Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses?. J Virol 1994, 68:2889-2897. 236777, 8151759.
35. Zhou Y, Chen X, Ushijima H, Frey TK. Analysis of base and codon usage by rubella virus. Arch Virol 2012, 157:889-899. 10.1007/s00705-012-1243-9, 22322905.
36. Berkhout B. Structure and function of the human immunodeficiency virus leader RNA. Prog Nucleic Acid Res Mol Biol 1996, 54:1-34.
37. Zsiros J, Jebbink MF, Lukashov VV, Voute PA, Berkhout B. Biased nucleotide composition of the genome of HERV-K related endogenous retroviruses and its evolutionary implications. J Mol Evol 1999, 48:102-111. 10.1007/PL00006437, 9873082.
38. van Weringh A, Ragonnet-Cronin M, Pranckeviciene E, Pavon-Eternod M, Kleiman L, Xia X. HIV-1 modulates the tRNA pool to improve translation efficiency. Mol Biol Evol 2011, 28:1827-1834. 10.1093/molbev/msr005, 3098512, 21216840.
39. Keating CP, Hill MK, Hawkes DJ, Smyth RP, Isel C, Le SY, et al. The A-rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA. Nucleic Acids Res 2009, 37:945-956. 10.1093/nar/gkn1015, 2647285, 19106143.
40. Schneider R, Campbell M, Nasioulas G, Felber BK, Pavlakis GN. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J Virol 1997, 71:4892-4903. 191719, 9188551.
41. Hershberg R, Petrov DA. Selection on codon bias. Annu Rev Genet 2008, 42:287-299. 10.1146/annurev.genet.42.110807.091442, 18983258.
42. Goodenbour JM, Pan T. Diversity of tRNA genes in eukaryotes. Nucleic Acids Res 2006, 34:6137-6146. 10.1093/nar/gkl725, 1693877, 17088292.
43. Dittmar KA, Goodenbour JM, Pan T. Tissue-specific differences in human transfer RNA expression. PLoS Genet 2006, 2:e221. 10.1371/journal.pgen.0020221, 1713254, 17194224.
44. Parmley JL, Huynen MA. Clustering of codons with rare cognate tRNAs in human genes suggests an extra level of expression regulation. PLoS Genet 2009, 5:e1000548. 10.1371/journal.pgen.1000548, 2697378, 19578405.
45. Lavner Y, Kotlar D. Codon bias as a factor in regulating expression via translation rate in the human genome. Gene 2005, 345:127-138. 10.1016/j.gene.2004.11.035, 15716084.
46. Grantham P, Perrin P. AIDS virus and HTLV-I differ in codon choices. Nature 1986, 319:727-728.
47. Sharp PM. What can AIDS virus codon usage tell us?. Nature 1986, 324:114. 10.1038/324114a0, 3641061.
48. Chou KC, Zhang CT. Diagrammatization of codon usage in 339 human immunodeficiency virus proteins and its biological implication. AIDS Res Hum Retroviruses 1992, 8:1967-1976. 10.1089/aid.1992.8.1967, 1493047.
49. Zoubak S, Rynditch A, Bernardi G. Compositional bimodality and evolution of retroviral genomes. Gene 1992, 119:207-213. 10.1016/0378-1119(92)90273-R, 1398101.
50. Fitzgerald DJ, Bronson EC, Anderson JN. Compositional similarities between the human immunodeficiency virus and surface antigens of pathogens. AIDS Res Hum Retroviruses 1996, 12:99-106. 10.1089/aid.1996.12.99, 8834459.
51. D'Onofrio G, Jabbari K, Musto H, Bernardi G. The correlation of protein hydropathy with the base composition of coding sequences. Gene 1999, 238:3-14. 10.1016/S0378-1119(99)00257-7, 10570978.
52. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, Gregory TJ. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 1990, 265:10373-10382.
53. Haas J, Park EC, Seed B. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr Biol 1996, 6:315-324. 10.1016/S0960-9822(02)00482-7, 8805248.
54. Anson DS, Dunning KR. Codon-optimized reading frames facilitate high-level expression of the HIV-1 minor proteins. Mol Biotechnol 2005, 31:85-88. 10.1385/MB:31:1:085, 16118417.
55. Ngumbela KC, Ryan KP, Sivamurthy R, Brockman MA, Gandhi RT, Bhardwaj N, et al. Quantitative effect of suboptimal codon usage on translational efficiency of mRNA encoding HIV-1 gag in intact T cells. PLoS One 2008, 3:e2356. 10.1371/journal.pone.0002356, 2387063, 18523584.
56. Kotsopoulou E, Kim VN, Kingsman AJ, Kingsman SM, Mitrophanous KA. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J Virol 2000, 74:4839-4852. 10.1128/JVI.74.10.4839-4852.2000, 112007, 10775623.
57. Marzio G, Vink M, Verhoef K, de RA, Berkhout B. Efficient human immunodeficiency virus replication requires a fine-tuned level of transcription. J Virol 2002, 76:3084-3088. 10.1128/JVI.76.6.3084-3088.2002, 135974, 11861878.
58. Lefebvre G, Desfarges S, Uyttebroeck F, Munoz M, Beerenwinkel N, Rougemont J, et al. Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell. J Virol 2011, 85:6205-6211. 10.1128/JVI.00252-11, 3126515, 21507965.
59. Meintjes PL, Rodrigo AG. Evolution of relative synonymous codon usage in Human Immunodeficiency Virus type-1. J Bioinform Comput Biol 2005, 3:157-168. 10.1142/S0219720005000953, 15751118.
60. Pandit A, Sinha S. Differential trends in the codon usage patterns in HIV-1 genes. PLoS One 2011, 6:e28889. 10.1371/journal.pone.0028889, 3245234, 22216135.
61. Shevelev IV, Hubscher U. The 3' 5' exonucleases. Nat Rev Mol Cell Biol 2002, 3:364-376. 10.1038/nrm804, 11988770.
62. Thomas MJ, Platas AA, Hawley DK. Transcriptional fidelity and proofreading by RNA polymerase II. Cell 1998, 93:627-637. 10.1016/S0092-8674(00)81191-5, 9604937.
63. Roberts JD, Bebenek K, Kunkel TA. The accuracy of reverse transcriptase from HIV-1. Science 1988, 242:1171-1173. 10.1126/science.2460925, 2460925.
64. Preston BD, Poiesz BJ, Loeb LA. Fidelity of HIV-1 reverse transcriptase. Science 1988, 242:1168-1171. 10.1126/science.2460924, 2460924.
65. O'Neil PK, Sun G, Yu H, Ron Y, Dougherty JP, Preston BD. Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J Biol Chem 2002, 277:38053-38061. 10.1074/jbc.M204774200, 12151398.
66. Abram ME, Ferris AL, Shao W, Alvord WG, Hughes SH. Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication. J Virol 2010, 84:9864-9878. 10.1128/JVI.00915-10, 2937799, 20660205.
67. Boyer JC, Bebenek K, Kunkel TA. Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates. Proc Natl Acad Sci U S A 1992, 89:6919-6923. 10.1073/pnas.89.15.6919, 49616, 1379727.
68. Martinez MA, Vartanian JP, Wain-Hobson S. Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations. Proc Natl Acad Sci U S A 1994, 91:11787-11791. 10.1073/pnas.91.25.11787, 45320, 7527543.
69. Cohen A, Barankiewicz J, Lederman HM, Gelfand EW. Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J Biol Chem 1983, 258:12334-12340.
70. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003, 424:94-98. 10.1038/nature01707, 1350966, 12808465.
71. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424:99-103. 10.1038/nature01709, 12808466.
72. Jern P, Russell RA, Pathak VK, Coffin JM. Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance. PLoS Pathog 2009, 5:e1000367. 10.1371/journal.ppat.1000367, 2659435, 19343218.
73. Elder JH, Lerner DL, Hasselkus-Light CS, Fontenot DJ, Hunter E, Luciw PA, et al. Distinct subsets of retroviruses encode dUTPase. J Virol 1992, 66:1791-1794. 240941, 1310783.
74. Abergel C, Robertson DL, Claverie JM. "Hidden" dUTPase sequence in human immunodeficiency virus type 1 gp120. J Virol 1999, 73:751-753. 103883, 9847382.
75. Turelli P, Guiguen F, Mornex JF, Vigne R, Querat G. dUTPase-minus caprine arthritis-encephalitis virus is attenuated for pathogenesis and accumulates G-to-A substitutions. J Virol 1997, 71:4522-4530. 191673, 9151845.
76. Lerner DL, Wagaman PC, Phillips TR, Prospero-Garcia O, Henriksen SJ, Fox HS, et al. Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase. Proc Natl Acad Sci U S A 1995, 92:7480-7484. 10.1073/pnas.92.16.7480, 41363, 7638216.
77. van der Kuyl AC. HIV infection and HERV expression: a review. Retrovirology 2012, 9:6. 10.1186/1742-4690-9-6, 3311604, 22248111.
78. Martinez MA, Sala M, Vartanian JP, Wain-Hobson S. Reverse transcriptase and substrate dependence of the RNA hypermutagenesis reaction. Nucleic Acids Res 1995, 23:2573-2578. 10.1093/nar/23.14.2573, 307076, 7544458.
79. Keulen W, Boucher C, Berkhout B. Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins. Antiviral Res 1996, 31:45-57. 10.1016/0166-3542(96)00944-8, 8793008.
80. Keulen W, Back NK, van Wijk A, Boucher CA, Berkhout B. Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase. J Virol 1997, 71:3346-3350. 191477, 9060708.
81. Vabret N, Bailly-Bechet M, Najburg V, Muller-Trutwin M, Verrier B, Tangy F. The biased nucleotide composition of HIV-1 triggers type I interferon response and correlates with subtype D increased pathogenicity. PLoS One 2012, 7:e33502. 10.1371/journal.pone.0033502, 3329495, 22529893.
82. Romani B, Engelbrecht S, Glashoff RH. Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif. Arch Virol 2009, 154:1579-1588. 10.1007/s00705-009-0481-y, 19669862.
83. Thielen BK, McNevin JP, McElrath MJ, Hunt BV, Klein KC, Lingappa JR. Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms. J Biol Chem 2010, 285:27753-27766. 10.1074/jbc.M110.102822, 2934643, 20615867.
84. Goila-Gaur R, Strebel K. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 2008, 5:51. 10.1186/1742-4690-5-51, 2443170, 18577210.
85. de Arellano ER, Alcami J, Lopez M, Soriano V, Holguin A. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants. Antiviral Res 2010, 88:152-159. 10.1016/j.antiviral.2010.08.007, 20713090.
86. Armitage AE, Deforche K, Chang CH, Wee E, Kramer B, Welch JJ, et al. APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon. PLoS Genet 2012, 8:e1002550. 10.1371/journal.pgen.1002550, 3310730, 22457633.
87. Suspene R, Rusniok C, Vartanian JP, Wain-Hobson S. Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication. Nucleic Acids Res 2006, 34:4677-4684. 10.1093/nar/gkl555, 1635257, 16963778.
88. Deforche K, Camacho R, Laethem KV, Shapiro B, Moreau Y, Rambaut A, et al. Estimating the relative contribution of dNTP pool imbalance and APOBEC3G/3F editing to HIV evolution in vivo. J Comput Biol 2007, 14:1105-1114. 10.1089/cmb.2007.0073, 17985990.
89. Kumagai Y, Takeuchi O, Akira S. TLR9 as a key receptor for the recognition of DNA. Adv Drug Deliv Rev 2008, 60:795-804. 10.1016/j.addr.2007.12.004, 18262306.
90. Fitzgerald-Bocarsly P, Jacobs ES. Plasmacytoid dendritic cells in HIV infection: striking a delicate balance. J Leukoc Biol 2010, 87:609-620. 10.1189/jlb.0909635, 2858309, 20145197.
91. Evans VA, Lal L, Akkina R, Solomon A, Wright E, Lewin SR, et al. Thymic plasmacytoid dendritic cells are susceptible to productive HIV-1 infection and efficiently transfer R5 HIV-1 to thymocytes in vitro. Retrovirology 2011, 8:43. 10.1186/1742-4690-8-43, 3118182, 21639903.
92. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S, et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A 2001, 98:9237-9242. 10.1073/pnas.161293498, 55404, 11470918.
93. Los Alamos National Laboratory HIV Databases http://www.hiv.lanl.gov/content/index, Los Alamos National Laboratory HIV Databases.
94. Chang JJ, Lacas A, Lindsay RJ, Doyle EH, Axten KL, Pereyra F, et al. Differential regulation of toll-like receptor pathways in acute and chronic HIV-1 infection. AIDS 2012, 26:533-541. 10.1097/QAD.0b013e32834f3167, 22210629.
95. Martinelli E, Cicala C, Van RD, Goode DJ, Macleod K, Arthos J, et al. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 2007, 104:3396-3401. 10.1073/pnas.0611353104, 1805537, 17360657.
96. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529. 10.1126/science.1093620, 14976262.
97. Meier A, Alter G, Frahm N, Sidhu H, Li B, Bagchi A, et al. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 2007, 81:8180-8191. 10.1128/JVI.00421-07, 1951290, 17507480.
98. Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG, et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005, 115:3265-3275. 10.1172/JCI26032, 1253628, 16224540.
99. Han X, Li X, Yue SC, Anandaiah A, Hashem F, Reinach PS, et al. Epigenetic regulation of tumor necrosis factor alpha (TNFalpha) release in human macrophages by HIV-1 single-stranded RNA (ssRNA) is dependent on TLR8 signaling. J Biol Chem 2012, 287:13778-13786. 10.1074/jbc.M112.342683, 22393042.
100. Solis M, Nakhaei P, Jalalirad M, Lacoste J, Douville R, Arguello M, et al. RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I. J Virol 2011, 85:1224-1236. 10.1128/JVI.01635-10, 3020501, 21084468.
101. Berg RK, Melchjorsen J, Rintahaka J, Diget E, Soby S, Horan KA, et al. Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA. PLoS One 2012, 7:e29291. 10.1371/journal.pone.0029291, 3250430, 22235281.
102. Wreschner DH, McCauley JW, Skehel JJ, Kerr IM. Interferon action-sequence specificity of the ppp(A2'p)nA-dependent ribonuclease. Nature 1981, 289:414-417. 10.1038/289414a0, 6162102.
103. Floyd-Smith G, Slattery E, Lengyel P. Interferon action: RNA cleavage pattern of a (2'-5')oligoadenylate-dependent endonuclease. Science 1981, 212:1030-1032. 10.1126/science.6165080, 6165080.
104. Schroder HC, Ugarkovic D, Wenger R, Reuter P, Okamoto T, Muller WE. Binding of Tat protein to TAR region of human immunodeficiency virus type 1 blocks TAR-mediated activation of (2'-5')oligoadenylate synthetase. AIDS Res Hum Retroviruses 1990, 6:659-672. 10.1089/aid.1990.6.659, 1694453.
105. Maitra RK, McMillan NA, Desai S, McSwiggen J, Hovanessian AG, Sen G, et al. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 1994, 204:823-827. 10.1006/viro.1994.1601, 7524241.
106. Maitra RK, Silverman RH. Regulation of human immunodeficiency virus replication by 2',5'-oligoadenylate-dependent RNase L. J Virol 1998, 72:1146-1152. 124589, 9445011.
107. Carter WA, Strayer DR, Brodsky I, Lewin M, Pellegrino MG, Einck L, et al. Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex. Lancet 1987, 1:1286-1292.
108. Martinand C, Montavon C, Salehzada T, Silhol M, Lebleu B, Bisbal C. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells. J Virol 1999, 73:290-296. 103833, 9847332.
109. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474:654-657. 10.1038/nature10117, 21613998.
110. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474:658-661. 10.1038/nature10195, 3179858, 21720370.
111. Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 2011, 480:379-382. 10.1038/nature10623, 22056990.
112. Ayinde D, Casartelli N, Schwartz O. Restricting HIV the SAMHD1 way: through nucleotide starvation. Nat Rev Microbiol 2012, 10:675-680. 10.1038/nrmicro2862, 22926205.
113. Li M, Kao E, Gao X, Sandig H, Limmer K, Pavon-Eternod M, et al. Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature 2012, 491:125-128. 10.1038/nature11433, 23000900.
114. Doehle BP, Chang K, Rustagi A, McNevin J, McElrath MJ, Gale M. Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism. J Virol 2012, 86:8367-8374. 10.1128/JVI.00423-12, 22593165.
115. Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC, et al. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2004, 2:E234. 10.1371/journal.pbio.0020234, 509299, 15314653.
116. Macaya G, Thiery JP, Bernardi G. An approach to the organization of eukaryotic genomes at a macromolecular level. J Mol Biol 1976, 108:237-254. 10.1016/S0022-2836(76)80105-2, 826644.
117. Varriale A, Bernardi G. Distribution of DNA methylation, CpGs, and CpG islands in human isochores. Genomics 2010, 95:25-28. 10.1016/j.ygeno.2009.09.006, 19800400.
118. Kettmann R, Meunier-Rotival M, Cortadas J, Cuny G, Ghysdael J, Mammerickx M, et al. Integration of bovine leukemia virus DNA in the bovine genome. Proc Natl Acad Sci U S A 1979, 76:4822-4826. 10.1073/pnas.76.10.4822, 413029, 228266.
119. Salinas J, Zerial M, Filipski J, Crepin M, Bernardi G. Nonrandom distribution of MMTV proviral sequences in the mouse genome. Nucleic Acids Res 1987, 15:3009-3022. 10.1093/nar/15.7.3009, 340712, 3031617.
120. Roy-Engel AM. LINEs, SINEs and other retroelements: do birds of a feather flock together?. Front Biosci 2012, 17:1345-1361. 10.2741/3991, 3364521, 22201808.
121. Costantini M, Auletta F, Bernardi G. The distributions of "new" and "old" Alu sequences in the human genome: the solution of a "mystery". Mol Biol Evol 2012, 29:421-427. 10.1093/molbev/msr242, 22057813.
122. Brady T, Lee YN, Ronen K, Malani N, Berry CC, Bieniasz PD, et al. Integration target site selection by a resurrected human endogenous retrovirus. Genes Dev 2009, 23:633-642. 10.1101/gad.1762309, 2658518, 19270161.
123. Duret L, Eyre-Walker A, Galtier N. A new perspective on isochore evolution. Gene 2006, 385:71-74.
124. Webster MT, Smith NG, Ellegren H. Compositional evolution of noncoding DNA in the human and chimpanzee genomes. Mol Biol Evol 2003, 20:278-286. 10.1093/molbev/msg037, 12598695.